Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.

Main|Search|PHGKB


Last Posted: Dec 17, 2017

---

• Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.  
  Gschwantler-Kaulich Daphne et al. PloS one 2017 (12) e0189641
• Germline BRCA mutation in male carriers-ripe for precision oncology?  
  Leão Ricardo Romão Nazário et al. Prostate cancer and prostatic diseases 2017 Dec
• Professionals' knowledge, attitude and referral behaviour of preimplantation genetic diagnosis for hereditary breast and ovarian cancer.  
  Gietel-Habets J J G et al. Reproductive biomedicine online 2017 Dec
• Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.  
  Hull Leland E et al. American journal of preventive medicine 2017 Dec
• BRCA 1 and 2 mutation status: the elephant in the room during oncofertility counseling for young breast cancer patients.  
  Paluch-Shimon S et al. Annals of oncology : official journal of the European Society for Medical Oncology 2017 Dec
• Considering BRCA Genes: Knowledge Improves Outcomes  
  UC TV video, November 2017
• Systematic review of the empirical investigation of resources to support decision-making regarding BRCA1 and BRCA2 genetic testing in women with breast cancer.  
  Grimmett Chloe et al. Patient education and counseling 2017 Nov
• An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers.  
  Madorsky-Feldman Dana et al. Breast cancer research and treatment 2016 Jun 157(2) 319-327
• BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management.  
  Lee Michelle V et al. Radiographics : a review publication of the Radiological Society of North America, Inc 37(4) 1005-1023
• Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?  
  Peccatori Fedro Alessandro et al. Human reproduction (Oxford, England) 2017 Dec 1-7
• Outcomes of retesting BRCA negative patients using multigene panels.  
  Yadav Siddhartha et al. Familial cancer 2017 Jul 16(3) 319-328
• The Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers without a First-Degree Relative with Breast Cancer.  
  Metcalfe K A et al. Clinical genetics 2017 Dec
• Testing for BRCA1/2 Mutations.  
  Sefton Philip et al. JAMA 2017 11 (20) 2054
• Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a "Traceback" approach.  
  Moss Haley A et al. Genetic epidemiology 2017 Nov
• BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?  
  Alemar Bárbara et al. PloS one 2017 12(11) e0187630
• BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.  
  Nilsson Martin P et al. Breast cancer research and treatment 2017 Nov

more